HAIFA, Israel, Sept. 6, 2011 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR) announced today that Company executives will be presenting at five leading scientific and financial events in the U.S. during the month of September. The presentations will focus on Pluristem’s work towards the potential development of placenta-derived stem cell treatments for a variety of illnesses as well as on the company’s strategy.
